Sedana Medical AB (publ)
STO:SEDANA

Watchlist Manager
Sedana Medical AB (publ) Logo
Sedana Medical AB (publ)
STO:SEDANA
Watchlist
Price: 12.38 SEK 4.74% Market Closed
Market Cap: 1.2B SEK
Have any thoughts about
Sedana Medical AB (publ)?
Write Note

Sedana Medical AB (publ)
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Sedana Medical AB (publ)
Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Sedana Medical AB (publ)
STO:SEDANA
Long-Term Debt
kr3.5m
CAGR 3-Years
-11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Elekta AB (publ)
STO:EKTA B
Long-Term Debt
kr5.9B
CAGR 3-Years
15%
CAGR 5-Years
11%
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Long-Term Debt
kr0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
CellaVision AB
STO:CEVI
Long-Term Debt
kr15m
CAGR 3-Years
-42%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Getinge AB
STO:GETI B
Long-Term Debt
kr5B
CAGR 3-Years
-14%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Long-Term Debt
kr3.2B
CAGR 3-Years
4%
CAGR 5-Years
2%
CAGR 10-Years
N/A
No Stocks Found

Sedana Medical AB (publ)
Glance View

Market Cap
1.2B SEK
Industry
Health Care

Sedana Medical AB is a medical technology company, which engages in the development, manufacture, and sale of medical devices and drug development for future projects around AnaConDa. The company is headquartered in Danderyd, Stockholm. The company went IPO on 2017-06-21. The company develops, markets and sales medical devices and conducts drug development for future projects around AnaConDa technology. The AnaConDa technology delivery enables of volatile anaesthetics to invasively ventilated patients. The products portfolio comprises disposable medical devices AnaConDa for administration of volatile anaesthetics, AnaConDa syringes, FlurAbsorb charcoal filters for removing halogenated hydrocarbon anaesthetic gases, different lines and connectors which can be used to connect the FlurAbsorb filter, adaptors, among others. The Company’s main shareholders are board members, Linc AB and Magiola Consulting AB.

SEDANA Intrinsic Value
7.85 SEK
Overvaluation 37%
Intrinsic Value
Price

See Also

What is Sedana Medical AB (publ)'s Long-Term Debt?
Long-Term Debt
3.5m SEK

Based on the financial report for Sep 30, 2024, Sedana Medical AB (publ)'s Long-Term Debt amounts to 3.5m SEK.

What is Sedana Medical AB (publ)'s Long-Term Debt growth rate?
Long-Term Debt CAGR 3Y
-11%

Over the last year, the Long-Term Debt growth was 210%. The average annual Long-Term Debt growth rates for Sedana Medical AB (publ) have been -11% over the past three years .

Back to Top